|
Delayed
NYSE
21:00:00 04/09/2026 BST
|
5-day change | 1st Jan Change | ||
| 24.35 USD | -0.04% |
|
-1.54% | -21.45% |
| 08-14 | Oppenheimer Adjusts Pelthos Therapeutics PT to $64 From $66, Maintains Outperform Rating | MT |
| 08-13 | Pelthos Therapeutics Inc., Q2 2026 Earnings Call, Aug 13, 2026 |
Chart: Technical Analysis
NYSEUSD
| Markets | Quality | ||
|---|---|---|---|
NYSE
| PTHS | Delayed | |
CBOE
| PTHS | Real-time |
Technical analysis trends
| Short Term | Mid-Term | Long Term | |
|---|---|---|---|
| Trend | Bearish | Neutral | Neutral |
| Resistance | 26.66 | 29.5 | 34.4 |
| Spread/Res. | -8.66% | -17.46% | -29.22% |
| Spread/Supp. | +1.12% | +19.36% | +19.36% |
| Support | 24.08 | 20.4 | 20.4 |
MarketScreener's Technical Analysis Ratings
| Short Term Timing | |
|---|---|
| Middle Term Timing | |
| Long Term Timing | |
| RSI | |
| Bollinger Spread | |
| Unusual Volumes |
- Stock Market
- Stocks
- PTHS Stock
- Charts Pelthos Therapeutics Inc.
Select your edition
All financial news and data tailored to specific country editions
